BITEPRO
15.10.2019 16:02:07 CEST | Business Wire | Press release
According to British firm BitePRO , teachers and education professionals are at increased risk of being bitten by pupils and the consequences can be severe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191015005707/en/
Human bites can more dangerous than animal bites because of the large quantity and types of bacteria and viruses contained in the human mouth. Human bites that break the skin can become severely infected.
According to several medical sources, human bites have been shown to transmit hepatitis B, hepatitis C, herpes simplex virus (HSV) syphilis, tuberculosis, actinomycosis, tetanus and even the human immunodeficiency virus (HIV).
Robert Kaiser, CEO of BitePRO a firm specialised in bite resistant clothing states: “We are fully aware of teachers working in special educational needs schools or units for pupils with severe mental and behavioural problems who were bitten so hard, so they had to be given vaccinations against infectious diseases and viruses such as Hepatitis B. Many also required immediate surgery.”
“Regrettably, there is still a culture in some schools, particularly where pupils have severe behavioural problems, that being assaulted is all part of the job.”
Recently, teachers seem to talk openly about their daily experiences of being bitten, and their visits to hospitals. This is most certainly the case.
Brett Bigham, Oregon’s Teacher of the Year in 2014 reported to have been bitten so badly that he was sent to the hospital.
In October 2019 a Canberra public school worker was repeatedly bitten by one of her students. She was injured on a weekly basis, for six months, by a child with a mental disability. In an interview with local media she stated: “"I was bitten on the arms; I was bitten on the stomach and I was bitten on the leg. That was day one."
The ‘News and Features from the National Education Association’ admitted or rather stated on the 20 June 2019 that many teachers, administrators, and education support professionals (ESPs) are at risk of being bitten while at work.
Educational professionals around the world are now rightly calling for greater protection from children who bite them. Human teeth breaking their skin and leading to serious injury, infections, long term trauma and require complex surgery cannot be part of their daily routine.
Many have now walked away from a profession they were once extremely passionate about, because medical experts have been able to identify that they suffer from PTSD (Post Traumatic Stress Disorder), an illness, usually associated to soldiers returning from wars, having witnessed severe levels of violence.
According to Robert Kaiser, bite resistant arm guards might not change the behaviour of violent children, or the behaviour of children diagnosed with specific mental illnesses. But there is no question about it, such type of highly protective clothing will reduce the risk of injury and infections. It will prevent immense long-term emotional distress to teachers. It will help them to continue working within a sector they are passionate about.
Kayleigh Davis, Senior Consultant at BitePRO is also keen to point out some vital legal information: “Today’s legal environment will require a risk assessment to be conducted, highlighting any realistic risk employees are being exposed to e.g. being bitten by a pupil.”
“The purpose of such is to very clearly identifying a) the precise risk, b) the potential liability and c) the implementation of effective mitigating measures. I believe that BitePRO should be considered as one of many mitigations measures you can utilise and implement to reduce a realistic risk faced by today’s educational professionals.”
“Failing to do so can ultimately result in liability claims and legal action being taken against your organisation by either an injured employee or indeed an overseeing government body.”
The Portland Tribune reported on 01 February 2019 that eight educational assistants are suing Portland Public Schools and several administrators for $3.6 million alleging the special needs students they were supposed to assist frequently assaulted them by biting and scratching etc. The lawsuit accused the district partly of negligence. The lawsuit claimed the district and administrators did not sufficiently protect the educational assistants or students.
The fact of the matter is a school and any other educational facility is required to provide a safe and healthy workplace: It is not optional. It is the law.
For any product related questions, please email info@bite-pro.com .
### END
About BitePRO:
The BitePRO brand is part of PPSS Group’s global operation. PPSS Group is specialised in the development, manufacturing and supply of high-performance personal protective equipment, offering unrivalled protection from edged weapons, blunt force trauma and even human bites. Please follow BitePRO on social media: Facebook , LinkedIn , Twitter and Instagram .
View source version on businesswire.com: https://www.businesswire.com/news/home/20191015005707/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
